214 related articles for article (PubMed ID: 37270644)
1. Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.
Turner JA; Fredrickson MA; D'Antonio M; Katsnelson E; MacBeth M; Van Gulick R; Chimed TS; McCarter M; D'Alessandro A; Robinson WA; Couts KL; Pelanda R; Klarquist J; Tobin RP; Torres RM
Nat Commun; 2023 Jun; 14(1):3214. PubMed ID: 37270644
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.
Oda SK; Strauch P; Fujiwara Y; Al-Shami A; Oravecz T; Tigyi G; Pelanda R; Torres RM
Cancer Immunol Res; 2013 Oct; 1(4):245-55. PubMed ID: 24455753
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.
Torres RM; Turner JA; D'Antonio M; Pelanda R; Kremer KN
Immunol Rev; 2023 Aug; 317(1):203-222. PubMed ID: 37096808
[TBL] [Abstract][Full Text] [Related]
4. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
Jenkin KA; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8
Matas-Rico E; Frijlink E; van der Haar Àvila I; Menegakis A; van Zon M; Morris AJ; Koster J; Salgado-Polo F; de Kivit S; Lança T; Mazzocca A; Johnson Z; Haanen J; Schumacher TN; Perrakis A; Verbrugge I; van den Berg JH; Borst J; Moolenaar WH
Cell Rep; 2021 Nov; 37(7):110013. PubMed ID: 34788605
[TBL] [Abstract][Full Text] [Related]
6. LPA
Mathew D; Kremer KN; Strauch P; Tigyi G; Pelanda R; Torres RM
Front Immunol; 2019; 10():1159. PubMed ID: 31231367
[TBL] [Abstract][Full Text] [Related]
7. LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation.
Kremer KN; Buser A; Thumkeo D; Narumiya S; Jacobelli J; Pelanda R; Torres RM
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118816119. PubMed ID: 35394866
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion
Mathew D; Torres RM
Front Immunol; 2020; 11():531910. PubMed ID: 33584637
[TBL] [Abstract][Full Text] [Related]
9. The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages.
Zhang D; Shi R; Xiang W; Kang X; Tang B; Li C; Gao L; Zhang X; Zhang L; Dai R; Miao H
Signal Transduct Target Ther; 2020 Mar; 5(1):24. PubMed ID: 32296017
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
[TBL] [Abstract][Full Text] [Related]
11. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
12. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5.
Wang M; He P; Han Y; Dong L; Yun CC
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1073-1092. PubMed ID: 33975030
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.
Dacheux MA; Norman DD; Tigyi GJ; Lee SC
Pharmacol Ther; 2023 May; 245():108414. PubMed ID: 37061203
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
Willier S; Butt E; Grunewald TG
Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype.
Plastira I; Bernhart E; Goeritzer M; DeVaney T; Reicher H; Hammer A; Lohberger B; Wintersperger A; Zucol B; Graier WF; Kratky D; Malle E; Sattler W
J Neuroinflammation; 2017 Dec; 14(1):253. PubMed ID: 29258556
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
17. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
18. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
[TBL] [Abstract][Full Text] [Related]
19. The Japanese lamprey (Lethenteron camtschaticum) expresses functional lysophosphatidic acid receptors.
Tamaki T; Kagawa N; Fukushima N
Biochem Biophys Res Commun; 2021 Sep; 568():1-7. PubMed ID: 34166971
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
